Lung oncology Clinical Trials in Yuma, AZ
As of June 2026, 2 paid clinical trials are recruiting for Lung oncology in Yuma, Arizona. Lung oncology trials investigate EGFR, ALK, KRAS, and other driver-mutation targeted therapies alongside immunotherapy combinations for non-small cell, small cell, and mesothelioma studies. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
2 clinical trials for Lung oncology
·Clear filters·↓ Download CSVA Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
About research studies in Yuma
Yuma has approximately 9 recruiting research studies across a wide range of therapeutic areas. Arizona is home to Mayo Clinic Arizona, Banner - University Medical Center, and TGen (Translational Genomics Research Institute), with active research in oncology and precision medicine.
Top Research Study Locations in Yuma
Researchers run research studies in Yuma, AZ at 8 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Yuma Clinical Trials | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Heart Failure With Mildly Reduced Ejection Fraction | 2 |
| Anthos Investigative Site 9927 | Atrial Fibrillation (AF) | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Onvida Health Yuma Medical Center | Malignant Solid Neoplasm | 1 |
| Onvida Health Yuma Medical Center /ID# 253625 | Non Small Cell Lung Cancer | 1 |
| Site 187 | Major Depressive Disorder | 1 |
| Site 6087 | Bipolar Disorder I or II With a Major Depressive Episode | 1 |
| YUMA REGIONAL MEDICAL CENTER CANCER CENTER ( Site 0020) | Non-small Cell Lung Cancer | 1 |
Active & Upcoming Studies in Yuma (2026)
Recruiting trials in Yuma grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cardiovascular (4 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Cancer & tumors (2 active studies)
- A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) · Phase 3 · Merck Sharp & Dohme LLC
- A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) · Phase 3 · AbbVie
Diabetes & metabolic (2 active studies)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity · Phase 3 · Amgen
Mental health & behavior (1 active study)
- ALTO-100 in Bipolar Disorder With Depression (BD-D) · Phase 2 · Alto Neuroscience
Common conditions studied in Yuma
- Hypertension (2 active studies). Hypertension research tests new antihypertensive drug classes, renal denervation devices, and fixed-dose combinations for resistant disease.
- Atrial Fibrillation (AF) (1 active study). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
- Bipolar Disorder I or II With a Major Depressive Episode (1 active study). Bipolar disorder studies explore mood stabilizers, novel adjunctive agents, and digital monitoring tools to reduce relapse.
- Cardiovascular Diseases (1 active study). Recruiting Cardiovascular Diseases studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Diabetes Mellitus, Type 2 (1 active study). Diabetes trials evaluate new insulin formulations, GLP-1 receptor agonists, continuous glucose monitoring technologies, and disease-modifying therapies.
- Heart Failure With Mildly Reduced Ejection Fraction (1 active study). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
Leading research sponsors in Yuma
- Alto Neuroscience
- AbbVie
- Alnylam Pharmaceuticals
- Amgen
- Anthos Therapeutics, Inc.
Local regulations and guidelines
Clinical trials in Arizona are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Arizona research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Yuma. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Yuma
Hipa.ai aggregates every recruiting study in Yuma from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Yuma?
There are approximately 9 recruiting clinical trials in Yuma, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Yuma pay participants?
Most recruiting trials in Yuma compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Yuma?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Yuma?
The most common conditions under active study in Yuma include Hypertension (2), Atrial Fibrillation (AF) (1), Bipolar Disorder I or II With a Major Depressive Episode (1), Cardiovascular Diseases (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Yuma?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Yuma on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Yuma?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Yuma?
Recruiting research sites in Yuma include Yuma Clinical Trials, Anthos Investigative Site 9927, Clinical Trial Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Yuma right now?
The largest active categories in Yuma are Cardiovascular (4), Cancer & tumors (2), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.